| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 检测服务(元) | 937,486.87 | 2,156,238.45 | 1,082,839.21 | - | 962,174.23 |
| 研发服务(元) | 4,585,939.09 | 26,344,912.37 | 1,072,230.90 | 2,023,467.80 | 955,242.45 |
| 药品销售(元) | 918,142,038.40 | 1,442,369,358.44 | 641,228,574.02 | 1,005,620,867.08 | 417,820,494.24 |
| 技术授权(元) | 213,391,600.00 | 904,035,502.80 | 88,050,528.19 | - | - |
| 营业成本(元) | |||||
| 检测服务(元) | 396,146.33 | 914,454.00 | 395,293.10 | - | 379,396.51 |
| 研发服务(元) | 2,962,090.47 | 14,388,067.11 | 508,148.08 | 835,690.24 | 383,276.90 |
| 药品销售(元) | 115,588,484.28 | 175,810,396.08 | 75,809,899.57 | 136,894,165.89 | 59,377,085.62 |
| 技术授权(元) | - | - | - | - | - |
| 毛利(元) | |||||
| 检测服务(元) | 541,340.54 | 1,241,784.45 | 687,546.11 | - | 582,777.72 |
| 研发服务(元) | 1,623,848.62 | 11,956,845.26 | 564,082.82 | 1,187,777.56 | 571,965.55 |
| 药品销售(元) | 802,553,554.12 | 1,266,558,962.36 | 565,418,674.45 | 868,726,701.19 | 358,443,408.62 |
| 技术授权(元) | 213,391,600.00 | 904,035,502.80 | 88,050,528.19 | - | - |
| 毛利率(%) | |||||
| 检测服务(%) | 57.74 | 57.59 | 63.49 | - | 60.57 |
| 研发服务(%) | 35.41 | 45.39 | 52.61 | 58.70 | 59.88 |
| 药品销售(%) | 87.41 | 87.81 | 88.18 | 86.39 | 85.79 |
| 技术授权(%) | - | - | - | - | - |
| 收入构成(%) | |||||
| 检测服务(%) | 0.08 | 0.09 | 0.15 | - | 0.23 |
| 研发服务(%) | 0.40 | 1.11 | 0.15 | 0.20 | 0.23 |
| 药品销售(%) | 80.75 | 60.73 | 87.67 | 99.80 | 99.54 |
| 技术授权(%) | 18.77 | 38.07 | 12.04 | - | - |
| 毛利构成(%) | |||||
| 检测服务(%) | 0.05 | 0.06 | 0.11 | - | 0.16 |
| 研发服务(%) | 0.16 | 0.55 | 0.09 | 0.14 | 0.16 |
| 药品销售(%) | 78.83 | 58.00 | 86.36 | 99.86 | 99.68 |
| 技术授权(%) | 20.96 | 41.40 | 13.45 | - | - |